Respiratory Syncytial Virus Diagnostics Market Forecast, Trends, Industry Outlook To 2022: Grand View Research, Inc.

Respiratory Syncytial Virus Diagnostic Market Analysis by
Technology (Diagnostic Imaging, Flow Cytometry,
Immunoassays, Monoclonal Antibodies, Chromatography,
Gel Microdroplets and Molecular Diagnostics) End Use
(Nursing Home, Clinical Laboratories, Hospitals and
Physician Offices) Analysis, Regional Outlook, Competitive
Strategies and Forecasts, 2015 to 2022
Global respiratory syncytial virus diagnostic market is expected to register
exponential growth over the coming seven years due to increasing incidence rate of
childhood pneumonia. Also, unhygienic environment conditions and crowded
areas are further anticipated to lead to RSV (Respiratory Syncytial Virus) infection
thus driving the demand for RSV diagnostic tests over the forecast period.

For More Information on "Respiratory Syncytial Virus Diagnostic Market
Research Reports" visit - http://www.grandviewresearch.com/industryanalysis/respiratory-syncytial-virus-diagnostics-market
As per report published by the WHO (World Health Organization) in 2010, over
1.1 million people were diagnosed with pneumonia which are further anticipated to
grow thereby fueling the growth of RSV diagnostic tests market in near future. The
global respiratory syncytial virus diagnostic market is segmented on the basis of
technology and end use. By technology, the market is further sub segmented into
diagnostic imaging, flow cytometry, immunoassays, monoclonal antibodies,
chromatography, gel microdroplets and molecular diagnostics. The diagnostic
imaging market is expected to witness lucrative growth over the forecast period
owing to rising adoption of cost effective diagnostic procedures and incidences of
respiratory disorders.

By end use, the market includes nursing homes, clinical laboratories, hospitals and
physician offices. Regionally, North America held the largest growth share due to
favourable government policies, growing prevalence of respiratory syncytial virus
and increasing usage of technically advanced diagnostic procedures in this region.
European countries are anticipated to register rapid growth in near future owing to
increasing geriatric population base and awareness about various diagnostic
procedures. Similarly, Asia pacific region is expected to witness fastest growth
over the forecast period due to increasing prevalence of bronchitis & pneumonia
and rising disposable income in this region. Also, increasing healthcare awareness
and improved healthcare infrastructure is expected to result in speedy market
growth in Latin American region. The key players operating in global respiratory
syncytial virus diagnostic market are DiaSorin SPA, Abbott Laboratories, Ortho
Clinical Diagnostics, Bio Rad Laboratories Inc., EMD Millipore, Thermo Fisher
Scientific Corporation, BioMerieux, Novartis Diagnostics, Becton Dickinson
&Company, Hoffman La Roche Ltd. and Beckman Coulter.

The companies are adopting sustainability strategies such as collaborations,
research alliances and product modification to increase their market penetration.
For example, Becton Dickinson & Co. acquired Alverix in 2014, in manufacturing
Veritor System to gain presence in point of care diagnostics. The Veritor System
gives comprehensive results to healthcare professionals in much less time frame of
about 10 to 15 minutes by employing exhaustive advanced read technology
equipped with improved particle and compact reader.
Request TOC of “Respiratory Syncytial Virus Diagnostic Market Research
Reports" visit - http://www.grandviewresearch.com/industryanalysis/respiratory-syncytial-virus-diagnostics-market/request-toc
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals, materials,
healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058

Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/